Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells

被引:55
作者
Plano, Daniel [1 ]
Sanmartin, Carmen [1 ]
Moreno, Esther [1 ]
Prior, Celia [2 ]
Calvo, Alfonso [2 ]
Palop, Juan Antonio [1 ]
机构
[1] Univ Navarra, Dept Quim Organ & Farmaceut, Secc Sintesis, E-31008 Pamplona, Spain
[2] Univ Navarra, CIMA, Ctr Appl Med Res, Div Oncol, E-31008 Pamplona, Spain
关键词
organoselenium; cytotoxics; prostate;
D O I
10.1016/j.bmcl.2007.10.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 17 symmetrical substituted imidothiocarbamate and imidoselenocarbamate derivatives has been synthesized by reacting appropriately substituted acyl chlorides with alkyl imidothiocarbamates and alkyl imidoselenocarbamates. The antitumoral activities of the compounds were evaluated in vitro by examining their cytotoxic effects against human prostate cancer cells (PC-3). Five compounds showed interesting activity levels and 3p (IC50 = 1.85 mu M) was 7.3 times more active than the standard etoposide used in the treatment of prostate cancer and emerges as the most interesting compound. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6853 / 6859
页数:7
相关论文
共 50 条
  • [1] Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines
    Mahoney, Simon
    Arfuso, Frank
    Rogers, Pierra
    Hisheh, Susan
    Brown, David
    Millward, Michael
    Dharmarajan, Arun
    JOURNAL OF BIOSCIENCES, 2012, 37 (01) : 73 - 84
  • [2] Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines
    Simon Mahoney
    Frank Arfuso
    Pierra Rogers
    Susan Hisheh
    David Brown
    Michael Millward
    Arun Dharmarajan
    Journal of Biosciences, 2012, 37 : 73 - 84
  • [3] Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer
    Reddy, BS
    Wynn, TT
    ElBayoumy, K
    Upadhyaya, P
    Fiala, E
    Rao, CV
    ANTICANCER RESEARCH, 1996, 16 (3A) : 1123 - 1127
  • [4] Novel targeted pro-apoptotic agents for the treatment of prostate cancer
    Huang, Xu
    Zhang, Xiaoping
    Farahvash, Benyamin
    Olumi, Aria F.
    JOURNAL OF UROLOGY, 2007, 178 (05) : 1846 - 1854
  • [5] Chemoprevention of mammary cancer by diallyl selenide, a novel organoselenium compound
    ElBayoumy, K
    Chae, YH
    Upadhyaya, P
    Ip, C
    ANTICANCER RESEARCH, 1996, 16 (5A) : 2911 - 2915
  • [6] Ultrasound contrast agents and prostate cancer
    Frauscher, F
    Pallwein, L
    Klauser, A
    Berger, AP
    Koppelstaetter, F
    Gradl, J
    Schurich, M
    Bektic, J
    Pinggera, GM
    Halpern, EJ
    Horninger, W
    Bartsch, G
    Zur Nedden, D
    RADIOLOGE, 2005, 45 (06): : 544 - 551
  • [7] Evaluation of novel multifunctional organoselenium compounds as potential cholinesterase inhibitors against Alzheimer's disease
    Refaay, Dina A.
    Ahmed, Dalia M.
    Mowafy, Amr M.
    Shaaban, Saad
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (06) : 894 - 904
  • [8] Evaluation of novel multifunctional organoselenium compounds as potential cholinesterase inhibitors against Alzheimer’s disease
    Dina A. Refaay
    Dalia M. Ahmed
    Amr M. Mowafy
    Saad Shaaban
    Medicinal Chemistry Research, 2022, 31 : 894 - 904
  • [9] Chemoprevention of prostate cancer: Agents and study designs
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2007, 178 (03) : S9 - S13
  • [10] Stem cells in prostate and prostate cancer development
    Lam, JS
    Reiter, RE
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (02) : 131 - 140